1,25（OH）2D3对变应性鼻炎作用机制的研究进展

檀静怡; 刘涛

doi:10.13201/j.issn.1001-1781.2017.13.023

1,25（OH）2D3对变应性鼻炎作用机制的研究进展

檀静怡,
刘涛^,

- 山西医科大学第一临床医学院(太原, 030000)

详细信息

通讯作者: 刘涛,E-mail:sylt2009@126.com

中图分类号: R739.6

收稿日期: 2017-05-16

The regulatory mechanisms of 1,25（OH）2D3 in allergic rhinitis

TAN Jingyi,
LIU Tao^,

More Information

Corresponding author: LIU Tao, E-mail: sylt2009@126.com

Received Date: 16 May 2017

摘要

- 鼻炎,变应性 /
- 1,25二羟基维生素D3 /
- 树突状细胞 /
- T细胞 /
- 白介素-10
Abstract: Nearly 30 years at home and abroad, the study found that Vitamin D can adjust congenital and acquired immune at the same time. As a result, Vitamin D is expected to be used for prevention and treatment of allergic rhinitis. But about vitamin D supplement to the mechanism of action of allergic disease such as allergic rhinitis is still not clear, there is no consistent condusion, even some of the result also has certain contradiction, so vitamin D is not routinely used for clinical therapy. This review will help us to understand the mechanism of action of vitamin D for allergic rhinitis in the treatment of thinking in the future.
- rhinitis,allergy /
- 1,25(OH)2D3 /
- dendritic cell /
- T cell /
- interleukin-10

HTML全文

参考文献(36)

[1]	孔维佳, 周梁, 许庚, 等.耳鼻咽喉头颈外科学[M].北京:人民卫生出版社, 2005:288-294.
[2]	ROMAGNANI S.The role of lymphocytes in allergic disease[J].J Allergy Clin Immunol, 2000, 105:399-408.
[3]	DI ROSA M, MALAGUARNERA M, NICOLETTIF, et al.Vitamin D3:a helpful immuno-modulator[J].Immunology, 2011, 134:123-139.
[4]	EHLAYEL M S, BENER A, SABBAH A.Is high prevalence of vitaminD deficiency evidence for asthma and allergy risks[J]?Eur Ann Allergy Clin Immunol, 2011, 43:81-88.
[5]	WJST M, HYPPÓNEN E.Vitamin D serum levels and allergic rhinitis[J].Allergy, 2007, 62:1085-1086.
[6]	WEI R, CHRISTAKOS S.Mechanisms underlying the regulation of innate and adaptive immunity by VitaminD[J].Nutrients, 2015, 7:8251-8260.
[7]	WHITE J H.Vitamin D metabolism and signaling in the immune system[J].Rev Endocr Metab Disord, 2012, 13:21-29.
[8]	NISSEN J, VOGEL U, RAVN-HAREN G, et al.Common variants in CYP2R1and GC genes are both determinants of serum 25-hydroxyvitamin D concentrations after UVB irradiation and after consumption of vitamin D3-fortified bread and milk during winter in Denmark[J].Am J Clin Nutr, 2015, 101:218-227.
[9]	HAUSSLER M R, WHITFIELD G K, KANEKO L, et al.Molecular mechanisms of vitamin D action[J].Calcif Tissue Int, 2013, 92:77-98.
[10]	RYYNANEN J, CARLBERG C.Primary 1, 25-dihydroxyvitamin D3response of the interleukin 8gene cluster in human monocyte-and macrophage-like cells[J].PLoS One, 2013, 8:e78170-e78170.
[11]	CARLBERG C, CAMPBELL M J.Vitamin D receptor signaling mechanisms:integrated actions of a welldefined transcription factor[J].Steroids, 2013, 78:127-136.
[12]	CAO P P, SHI L L, XU K, et al.Dendritic cells in inflammatory sinonasal diseases[J].Clin Exp Allergy, 2016, 46:894-906.
[13]	PENNA G, AMUCHASTEGUI S, GIARRATANAN, et al.1, 25-Dihydroxyvitamin D3selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells[J].J Immunol, 2007, 178:145-153.
[14]	CANTORNA M T, SNYDER L, LIN Y D, et al.Vitamin D and 1, 25(OH) 2Dregulation of T cells[J].Nutrients, 2015, 7:3011-3021.
[15]	BARTELS L E, JORGENSEN S P, AGNHOLT J, et al.1, 25-dihydroxyvitamin D3and dexamethasone increase interleukin-10production in CD4+T cells from patients with Crohn's disease[J].Int Immunopharmacol, 2007, 7:1755-1764.
[15]	SOCHOROVA K, BUDINSKY V, ROZKOVA D, et al.paricalcitol (19-nor-1, 25-dihydrovitamin D2) and calcitriol (19-nor-1, 25-dihydrovitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells[J].Clin Immunol, 2009, 133:69-77.
[16]	SOCHOROVA K, BUDINSKY V, ROZKOVA D, et al.Paricalcitol (19-nor-1, 25-dihydrovitamin D2) and calcitriol (19-nor-1, 25-dihydrovitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells[J].Clin Immunol, 2009, 133:69-77.
[17]	PENNA G, AMUCHASTEGUI S, LAVERNY G, et al.Vitamin D receptor agonists in the treatment of autoimmune diseases:selective targeting of myeloid but not plasmacytoid dendritic cells[J].J Bone Miner Res, 2007, 2:V69-V73.
[18]	NGUYEN N L, CHEN K, MCALEER J, et al.Vitamin D regulation of OX40ligand in immune responses to Aspergillus fumigatus[J].Infect Immun, 2013, 81:1510-1519.
[19]	PROVVEDINI D M, TSOUKAS C D, DEFTOS L J, et al.1, 25-dihydroxyvitamin d3receptors in human leukocytes[J].Science, 1983, 221:1181-1183.
[20]	CHEN J, BRUCE D, CANTORNA M T.Vitamin d receptor expression controls proliferation of naive cd8+t cells and development of cd8 mediated gastrointestinal inflammation[J].BMC Immunol, 2014, 2172:15-16.
[21]	BRUCE D, CANTORNA M T.Intrinsic requirement for the vitaminD receptor in the development of CD8αα-expressing T cells[J].Immune, 2011, 185:2819-2825.
[22]	WADDELL A, ZHAO J, CANTORNA M T.NKTcells can help mediate the protective effects of 1, 25-dihydroxyvitamin D3in experimental autoimmune encephalomyelitis in mice[J].Int Immunol, 2015, 27:237-244.
[23]	YU S, CANTORNA M T.Epigenetic reduction in invariant nkt cells following in utero vitamin d deficiency in mice[J].J Immunol, 2011, 186:1384-1390.
[24]	PALMER M T, LEE Y K, MAYNARD C L, et al.Lineage-specific effects of 1, 25-dihydroxyvitamin D (3) on the development of effector CD4Tcells[J].JBoil Chem, 2011, 286:997-1004.
[25]	AZIZIEH F, ALYAHYA K O, RAGHUPATHY R.Association between levels of vitamin D and inflammatory markers in healthy women[J].J Inflamm Res, 2016, 9:51-57.
[26]	FARAJI F, RASTIN M, ARAB F L, et al.Effects of1, 25-dihydroxyvitamin D3on IL-17/IL-23axis, IFN-γand IL-4expression in systemic lupus erythematosus induced mice model[J].Iran J Basic Med Sci, 2016, 19:374-380.
[27]	KORF H, WENES M, STIJLEMANS B, et al.1, 25-Dihydroxyvitamin D (3) curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism[J].Immunobiology, 2012, 217:1292-1300.
[28]	KHOO A L, KOENEN H J, CHAI L Y, et al.Seasonal variation in vitamin D3levels is paralleled by changes in the peripheral blood human T cell compartment[J].PLoS One, 2012, 7:e29250-e29250.
[29]	MOORE K W, WAAL MALEFYT R, COOFFMANR L, et al.Interleukin-10and interleukin-10receptor[J].Ann Rev Immunol, 2001, 19:683-765.
[30]	XYSTRAKIS E, KUSUMAKAR S, BOSWELL S, et al.Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients[J].J Clin Invest, 2006, 116:146-155.
[31]	IAN H Q, CHENG L.The role of vitamin D in allergic rhinitis[J].Asia Pac Allergy, 2017, 7:65-73.
[32]	LAMBERG-ALLARDT C, BRUSTAD M, MEYERH E, et al.Vitamin D-a systematic literature review for the 5th edition of the Nordic Nutrition Recommendations[J].Food Nutr Res, 2013, 57:22671-22671.
[33]	SPIRO A, BUTTRISS J L.Vitamin D:an overview of vitamin D status and intake in Europe[J].Nutr Bull, 2014, 39:322-350.
[34]	VANDEVIJVERE S, AMSALKHIR S, VAN OYENH, et al.High prevalence of vitamin D deficiency in pregnant women:a national cross-sectional survey[J].PLoS One, 2012, 7:e43868-e43868.
[35]	DOGUR M, SULEYMAN A.Serum 25-hydroxyvitamin D3levels in children with allergic or nonallergic rhinitis[J].Int J Pediatr Otorhinolaryngol, 2016, 80:39-42.